NYSE:TFX

Teleflex - TFX Stock Forecast, Price & News

$204.03

-2.22 (-1.08%)

(As of 10/5/2022 11:43 AM ET)

Add

Compare

Today's Range: $202.09
▼
$205.29
50-Day Range: $201.46
▼
$266.53
52-Week Range: $199.92
▼
$382.46

Volume: 3,717 shs
Average Volume: 396,496 shs
Market Capitalization: $9.57 billion

P/E Ratio: 18.96
Dividend Yield: 0.65%
Price Target: $322.70

Teleflex MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 57.7% Upside
$322.70 Price Target
Short Interest: Healthy
2.88% of Shares Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.53
Upright™ Environmental Score
News Sentiment: 0.19
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 7.85%
From $13.12 to $14.15 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.68 out of 5 stars

Medical Sector

99th out of 1,087 stocks

Surgical & Medical Instruments Industry

9th out of 106 stocks

3.3

Analyst's Opinion

Consensus Rating
Teleflex has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 5 buy ratings, 5 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $322.70, Teleflex has a forecasted upside of 57.7% from its current price of $204.58.
Amount of Analyst Coverage
Teleflex has only been the subject of 3 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
2.88% of the outstanding shares of Teleflex have been sold short.
Short Interest Ratio / Days to Cover
Teleflex has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Teleflex has recently increased by 20.54%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Yield
Teleflex has a dividend yield of 0.65%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Teleflex does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Teleflex is 12.64%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Teleflex will have a dividend payout ratio of 9.61% next year. This indicates that Teleflex will be able to sustain or increase its dividend.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Teleflex has received a 53.08% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Wound closure devices", "Surgical clamps", and "Catheters" products. See details.
Environmental Sustainability
The Environmental Impact score for Teleflex is -1.53.

1.8

News and Social Media Coverage

News Sentiment
Teleflex has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Teleflex this week, compared to 6 articles on an average week.
Search Interest
4 people have searched for TFX on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Teleflex insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.28% of the stock of Teleflex is held by insiders.
Percentage Held by Institutions
95.91% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Teleflex are expected to grow by 7.85% in the coming year, from $13.12 to $14.15 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Teleflex is 19.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 116.79.
Price to Earnings Ratio vs. Sector
The P/E ratio of Teleflex is 19.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 80.77.
Price to Earnings Growth Ratio
Teleflex has a PEG Ratio of 2.06. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Teleflex has a P/B Ratio of 2.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Teleflex (NYSE:TFX) Stock

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Stock News Headlines

September 28, 2022 | markets.businessinsider.com

Teleflex Releases New Arrow Pressure Injectable Midline Catheter Portfolio In US, Canada

September 28, 2022 | finance.yahoo.com

Teleflex Completes Acquisition of Standard Bariatrics

September 27, 2022 | globenewswire.com

Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio - GlobeNewswire

September 27, 2022 | finance.yahoo.com

Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio

September 27, 2022 | americanbankingnews.com

Teleflex Incorporated (NYSE:TFX) Receives $325.60 Average PT from Analysts

September 26, 2022 | globenewswire.com

Anesthesia & Respiratory Devices Market Size Will Attain USD 49.9 Billion by 2030 growing at 6.5% CAGR - Exclusive Report by Acumen Research and Consulting - GlobeNewswire

September 26, 2022 | businesswire.com

Insights on the Flowable Hemostats Global Market to 2028 - Featuring Baxter International, Teleflex and Pfizer Among Others - ResearchAndMarkets.com - Business Wire

September 25, 2022 | finance.yahoo.com

Airway Management Devices Market Worth $3.1Bn, Globally, by 2028 at 6.9% CAGR - Exclusive Research Report by The Insight Partners - Yahoo Finance

September 25, 2022 | finance.yahoo.com

Is Now The Time To Look At Buying Teleflex Incorporated (NYSE:TFX)? - Yahoo Finance

September 25, 2022 | finance.yahoo.com

Is Now The Time To Look At Buying Teleflex Incorporated (NYSE:TFX)?

September 22, 2022 | benzinga.com

Expert Ratings for Teleflex - Teleflex (NYSE:TFX) - Benzinga

September 20, 2022 | nasdaq.com

Teleflex (TFX) Witnesses Lower UroLift Sales, Cost Woes - Nasdaq

September 20, 2022 | nasdaq.com

Teleflex Incorporated Shares Close in on 52-Week Low - Market Mover - Nasdaq

September 19, 2022 | finance.yahoo.com

Teleflex (TFX) Witnesses Lower UroLift Sales, Cost Woes - Yahoo Finance

September 15, 2022 | finance.yahoo.com

Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

September 14, 2022 | businesswire.com

Insights on the Urinary Catheters Global Market to 2027 - Featuring Cardinal Health, Teleflex Incorporated and Wellspect HealthCare Among Others - ResearchAndMarkets.com - Business Wire

September 12, 2022 | nasdaq.com

Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns - Nasdaq

September 9, 2022 | benzinga.com

Global Silicone Foley Catheter Market Report to 2027 - Featuring Medline, CR Bard, Teleflex and ConvaTe - Benzinga

September 6, 2022 | nasdaq.com

Teleflex is Now Oversold (TFX) - Nasdaq

September 6, 2022 | finance.yahoo.com

Peripheral IV Catheters Market Size-Share [2022-2029] | Is Projected to Reach USD 7,964.4 Million, with 6.2% of CAGR | Growth Rate, Key Players, Trends, Demand, Revenue, Challenges, Opportunities, & Forecast - Yahoo Finance

September 6, 2022 | finance.yahoo.com

USD 5.28 Bn growth in Wound Closure Devices Market 2026, Rising Demand For Cosmetic And Plastic Surgeries to Boost Growth - Technavio - Yahoo Finance

September 5, 2022 | globenewswire.com

Multi-lumen Central Venous Catheters More Preferred for Catheterization Owing to Flexibility & Durability Aspects, Says Fact.MR - GlobeNewswire

September 2, 2022 | au.finance.yahoo.com

Is Weakness In Teleflex Incorporated (NYSE:TFX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Yahoo Finance Australia

September 2, 2022 | finance.yahoo.com

Is Weakness In Teleflex Incorporated (NYSE:TFX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

August 31, 2022 | globenewswire.com

Teleflex to Present at the Morgan Stanley 20th Annual Global Healthcare Conference - GlobeNewswire

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Company Calendar

Last Earnings: 7/28/2022
Ex-Dividend for 9/15 Dividend: 8/12/2022
Dividend Payable: 9/15/2022
Today: 10/05/2022
Next Earnings (Estimated): 10/27/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:TFX
CUSIP: 87936910
CIK: 96943
Web: www.teleflex.com
Phone: (610) 225-6800
Fax: 215-553-5402
Employees: 14,000
Year Founded: 1943

Price Target and Rating

Average Stock Price Forecast: $322.70
High Stock Price Forecast: $430.00
Low Stock Price Forecast: $241.00
Forecasted Upside/Downside: +58.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $10.76
Trailing P/E Ratio: 18.96
Forward P/E Ratio: 15.55
P/E Growth: 2.06
Net Income: $485.37 million
Net Margins: 18.16%
Pretax Margin: 21.00%
Return on Equity: 16.84%
Return on Assets: 9.22%

Debt

Debt-to-Equity Ratio: 0.42
Current Ratio: 2.27
Quick Ratio: 1.43

Sales & Book Value

Annual Sales: $2.81 billion
Price / Sales: 3.41
Cash Flow: $18.25 per share
Price / Cash Flow: 11.18
Book Value: $80.15 per share
Price / Book: 2.55

Miscellaneous

Outstanding Shares: 46,900,000
Free Float: 46,305,000
Market Cap: $9.57 billion
Optionable: Optionable
Beta: 1.09

Social Links

Key Executives

Mr. Liam J. Kelly (Age 55)
Chairman, Pres & CEO
Comp: $3.01M

Mr. Thomas E. Powell (Age 60)
Exec. VP & CFO
Comp: $1.44M

Mr. Cameron P. Hicks (Age 57)
Corp. VP & Chief HR Officer
Comp: $771.45k

Mr. Jay White (Age 48)
Corp. VP & Pres of Global Commercial
Comp: $1.23M

Mr. James P. Winters
Corp. VP, Manufacturing and Supply Chain

Mr. John R. Deren
Corp. VP & Chief Accounting Officer

Mr. John Hsu C.F.A.
VP of Investor Relations

Mr. Daniel V. Logue (Age 48)
Corp. VP, Gen. Counsel & Sec.

Mr. Howard Cyr
Corp. VP & Chief Compliance Officer

Mr. Matt Tomkin
VP of Corp. Devel.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

TFX Stock - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?: 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TFX shares.
View TFX analyst ratings or view top-rated stocks.
What is Teleflex's stock price forecast for 2022?: 10 Wall Street research analysts have issued 12 month target prices for Teleflex's shares. Their TFX share price forecasts range from $241.00 to $430.00. On average, they predict the company's share price to reach $322.70 in the next year. This suggests a possible upside of 57.7% from the stock's current price.
View analysts price targets for TFX or view top-rated stocks among Wall Street analysts.
How have TFX shares performed in 2022?: Teleflex's stock was trading at $328.48 on January 1st, 2022. Since then, TFX stock has decreased by 37.7% and is now trading at $204.58.
View the best growth stocks for 2022 here.
When is Teleflex's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our TFX earnings forecast.
How were Teleflex's earnings last quarter?: Teleflex Incorporated (NYSE:TFX) announced its quarterly earnings results on Thursday, July, 28th. The medical technology company reported $3.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.34 by $0.05. The medical technology company had revenue of $704.50 million for the quarter, compared to analysts' expectations of $719.50 million. Teleflex had a net margin of 18.16% and a trailing twelve-month return on equity of 16.84%. The company's revenue was down 1.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.35 EPS.
Read the conference call transcript.
How often does Teleflex pay dividends? What is the dividend yield for Teleflex?: Teleflex announced a quarterly dividend on Thursday, July 28th. Stockholders of record on Monday, August 15th will be paid a dividend of $0.34 per share on Thursday, September 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.66%. The ex-dividend date is Friday, August 12th.
Read our dividend analysis for TFX.
Is Teleflex a good dividend stock?: Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.65%. The dividend payout ratio is 12.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.61% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?: Teleflex issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $13.00-$13.40 for the period, compared to the consensus estimate of $13.97. The company issued revenue guidance of $2.80 billion-$2.83 billion, compared to the consensus revenue estimate of $2.89 billion.
What is Liam Kelly's approval rating as Teleflex's CEO?: 73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.
What other stocks do shareholders of Teleflex own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).
What is Teleflex's stock symbol?: Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."
How do I buy shares of Teleflex?: Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Teleflex's stock price today?: One share of TFX stock can currently be purchased for approximately $204.58.
How much money does Teleflex make?: Teleflex (NYSE:TFX) has a market capitalization of $9.59 billion and generates $2.81 billion in revenue each year. The medical technology company earns $485.37 million in net income (profit) each year or $10.76 on an earnings per share basis.
How many employees does Teleflex have?: The company employs 14,000 workers across the globe.
How can I contact Teleflex?: Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.

This page (NYSE:TFX) was last updated on 10/5/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Teleflex - TFX Stock Forecast, Price & News

Teleflex MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Teleflex (NYSE:TFX) Stock

TFX Stock News Headlines

TFX Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

TFX Stock - Frequently Asked Questions

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™